T
Timothy R. Arnett
Researcher at University College London
Publications - 118
Citations - 7486
Timothy R. Arnett is an academic researcher from University College London. The author has contributed to research in topics: Osteoclast & Osteoblast. The author has an hindex of 43, co-authored 114 publications receiving 6795 citations. Previous affiliations of Timothy R. Arnett include New York State Department of Health.
Papers
More filters
Journal ArticleDOI
Bisphosphonates induce apoptosis in human breast cancer cell lines
TL;DR: An increase in the proportion of cells having morphological features characteristic of apoptosis, characteristic apoptotic changes in the nucleus, time-dependent increase inThe percentage of fragmented chromosomal DNA, down-regulation in bcl-2 protein and proteolytic cleavage of PARP, all indicate that bisphosphonates have direct anti-tumour effects on human breast cancer cells.
Journal ArticleDOI
Effect of pH on Bone Resorption by Rat Osteoclasts in Vitro
TL;DR: This is the first direct demonstration that low pH stimulates cell-mediated bone resorption, an observation that may have considerable physiological and pathophysiological significance.
Journal ArticleDOI
Wnt signalling in osteoblasts regulates expression of the receptor activator of NFκB ligand and inhibits osteoclastogenesis in vitro
TL;DR: Evidence that Wnts also regulate osteoclast formation and bone resorption is provided, through a mechanism involving transcriptional repression of the gene encoding the osteoclineogenic cytokine receptor activator of NFκB ligand (RANKL or TNFSF11) expressed by osteoblasts.
Journal ArticleDOI
Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.
TL;DR: The inhibitory effects of the peptides used in this study produced effects on dentine resorption which were generally weaker and variable, although osteoclast cell adhesion was consistently inhibited in an Arg-Gly-Asp (RGD)-dependent manner, demonstrating that osteOClast function can be disrupted by low concentrations of the anti-vitronectin receptor antibody, 23C6.
Journal ArticleDOI
Hypoxia is a major stimulator of osteoclast formation and bone resorption
Timothy R. Arnett,Daniel C Gibbons,JC Utting,Isabel R. Orriss,A Hoebertz,Martin Rosendaal,Sajeda Meghji +6 more
TL;DR: The experiments reveal a previously‐overlooked mechanism of considerable potential importance for the regulation of bone destruction, which may help explain the bone loss associated with a wide range of pathological states involving local or systemic hypoxia, and emphasize the importance of the vasculature in bone.